Annual report pursuant to Section 13 and 15(d)

Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)

v3.10.0.1
Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2018
Notes Tables  
Schedule of Franchisor Disclosure [Table Text Block]
    Year Ended
 December 31,
Franchised clinics:   2018   2017
Clinics open at beginning of period    
352
     
309
 
Opened or Purchased during the period    
47
     
41
 
Acquired or sold during the period    
(1
)    
6
 
Closed during the period    
(4
)    
(4
)
Clinics in operation at the end of the period    
394
     
352
 
    Year Ended
 December 31,
Company-owned or managed clinics:   2018   2017
Clinics open at beginning of period    
47
     
61
 
Opened during the period    
     
 
Acquired during the period    
1
     
 
Closed or Sold during the period    
     
(14
)
Clinics in operation at the end of the period    
48
     
47
 
                 
Total clinics in operation at the end of the period    
442
     
399
 
                 
Clinic licenses sold but not yet developed    
136
     
104
 
Executed letters of intent for future clinic licenses    
19
     
8
 
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
    Year Ended
 December 31,
    2018   2017
        (as adjusted)
Net income (loss)   $
253,083
    $
(3,432,412
)
                 
Weighted average common shares outstanding - basic    
13,669,107
     
13,245,119
 
Effect of dilutive securities:                
Unvested restricted stock and stock options    
362,609
     
 
Weighted average common shares outstanding - diluted    
14,031,717
     
13,245,119
 
                 
Basic earnings (loss) per share   $
0.02
    $
(0.26
)
Diluted earnings (loss) per share   $
0.02
    $
(0.26
)
    Year Ended
 December 31,
    2018   2017
Unvested restricted stock    
24,180
     
63,700
 
Stock options    
651,036
     
1,003,916
 
Warrants    
     
90,000
 
Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]
    As of
December 31, 2017
  Adjustments Due
to ASC 606
adoption
  As of
December 31, 2017
ASSETS  
(as reported)
 
 
 
(as adjusted)
Current assets:                        
Deferred franchise costs - current portion   $
484
 
  $
14
    $
498
 
Total current assets    
6,657
 
   
14
     
6,671
 
Deferred franchise costs, net of current portion    
813
 
   
1,500
     
2,313
 
Deposits and other assets    
612
 
   
12
     
623
 
Total assets   $
16,910
 
  $
1,526
    $
18,436
 
                         
LIABILITIES AND STOCKHOLDERS' EQUITY                        
Current liabilities:                        
Deferred franchise revenue - current portion   $
1,686
 
  $
308
    $
1,994
 
Other current liabilities    
49
 
   
104
     
153
 
Total current liabilities    
4,967
 
   
412
     
5,379
 
Deferred revenue, net of current portion    
4,693
 
   
4,859
     
9,553
 
Total liabilities    
12,011
 
   
5,271
     
17,283
 
Stockholders' equity:                        
Accumulated deficit    
(32,259
)
   
(3,745
)    
(36,004
)
Total stockholders' equity    
4,899
 
   
(3,745
)    
1,153
 
Total liabilities and stockholders' equity   $
16,910
 
  $
1,526
    $
18,436
 
    Year Ended
December 31, 2017
  Adjustments Due
to ASC 606
adoption
  Year Ended
December 31, 2017
    (as reported)       (as adjusted)
Revenues:                        
Franchise fees   $
1,442
    $
(61
)   $
1,382
 
Regional developer fees    
584
     
(185
)    
399
 
Total revenues    
25,164
     
(245
)    
24,919
 
Cost of revenues:                        
Franchise cost of revenues    
2,997
     
(88
)    
2,909
 
Total cost of revenues    
3,312
     
(88
)    
3,224
 
Loss from operations    
(3,175
)    
(157
)    
(3,332
)
Loss before income tax expense    
(3,239
)    
(157
)    
(3,397
)
Net loss and comprehensive loss   $
(3,275
)   $
(157
)   $
(3,432
)
                         
Loss per share:                        
Basic and diluted loss per share   $
(0.25
)   $
(0.01
)   $
(0.26
)